N.1 NEWS



2020

  • Singapore 10.3.20: Prof. Dean Ho participates in podcast with Chief Economics and Managing Director, DBS Bank, Dr. Taimur Baig to discuss the role that AI will have in combatting cancer and COVID-19. The podcast can be found here.

  • Singapore 28.2.20: Prof. Dean Ho publishes peer-reviewed perspective in Science pertaining to AI in Cancer Therapy. The paper can be found here.

  • Singapore 21.2.20: Assoc. Prof. Anqi Qiu is featured in NETFLIX series “Babies” for her groundbreaking work in newborn brain imaging and its role towards understanding long-term child development. Check out the series here.

2019

  • SINGAPORE 23.3.19: Prof. Dean Ho is featured in Straits Times article pertaining to AI-tailored cancer care. The full Straits Times article can be found at NUS News here.

Credit: Straits Times

Credit: Straits Times

  • SINGAPORE 19.3.19: A/Prof. Jason Lee publishes paper in Frontiers in Physiology pertaining to the importance of pre-exercise cooling and heat acclimatisation towards performance optimisation. The full Straits Times article can be found at NUS News here.

Credit: Straits Times

Credit: Straits Times

  • SINGAPORE 6.2.19: N.1 announces the registration of a new N-of-1 interventional human study on multitasking training (Clinicaltrials.gov: NCT03832101; PI: Dr. Christopher Asplund). The study estimates the enrollment of up to 100 subjects. More information on Clinicaltrials.gov can be found here.


  • SINGAPORE 10.1.19: N.1 Investigator Dr. Thomas Yeo publishes Science Advances article demonstrating the application of machine learning and fMRI to uncover novel insights into the cellular architecture of the human brain. This discovery may greatly impact the development of important new therapies and assessment modalities for neurological disorders. The paper can be found here.

    Read the NUS press release.


  • SINGAPORE 1.1.19: N.1 Director, Professor Dean Ho, has been elected to the US National Academy of Inventors (NAI). Election to the NAI is the highest professional accolade that is bestowed to academic inventors. Prof. Ho is the first NUS faculty member to be elected to the NAI. The press release can be found here.

Prof. Dean Ho, Provost’s Chair Professor and Director, SINAPSE (Image courtesy of the National University of Singapore).

Prof. Dean Ho, Provost’s Chair Professor and Director, SINAPSE (Image courtesy of the National University of Singapore).



2018

  • SINGAPORE 29.11.18: Based upon a collaboration with NCIS Director, Prof. Wee Joo Chng, Sanjay de Mel of NUH/NCIS and Prof. Dean Ho, SINAPSE announces registration of new interventional clinical study (NCT Phase 2/3-equivalent) pertaining to CURATE.AI-optimised multiple myeloma combination therapy. This prospective study will be conducted in collaboration with National University Hospital (NUH) and National University Cancer Institute (NCIS). More information can be found at: Clinicaltrials.gov: NCT03759093


  • SINGAPORE 1.11.18: N.1 congratulates Theodore Kee, Head of Clinical Studies, for receiving a Tony B Travel Award to attend the 2019 Society for Laboratory Automation and Screening (SLAS) conference in Washington, D.C. This 6,000+ attendee meeting features the latest innovation in drug development and screening at the interface of industry and academic/government research. The meeting is attended by the world’s largest pharmaceutical and medtech companies as well as leading luminaries. Theodore is among the few international award recipients. N.1 thanks the Society for Laboratory Automation. Read the news release here


  • SINGAPORE 25.10.18: N.1 investigators receive approval to commence N-of-1 clinical study for gastric cancer (info).


  • SINGAPORE 8.10.18: Dr. Thomas Yeo receives the Singapore Neuroscience Association Young Neuroscientist Award. Read the news story from NUS Engineering here.


  • SINGAPORE 31.8.18: Work from Prof. Dean Ho’s N.1 Labs team is featured on the cover of Advanced Therapeutics and covered in over 50 international news outlets. The NUS news release can be found here. Read the article.

  • SINGAPORE 8.8.18: Prof. Dean Ho’s team publishes article in Science Translational Medicine with Prof. Wee Joo Chng (NCIS/NUH and CSI Singapore) and Dr. Edward Chow (CSI Singapore) using AI to identify and optimise patient-specific, novel drug combinations for multiple myeloma. Read the article.

    Read the NUS press release.

  • SINGAPORE 1.8.18: Dr. Raghav Sundar receives the National Medical Research Council Research PhD Fellowship.


  • SINGAPORE 25.6.18: Dr. Hongliang Ren wins 2018 Interstellar Initiative Award, by Japan Agency for Medical R&D and New York Academy of Sciences.


  • SINGAPORE 4.6.18: Dr. Hongliang Ren wins 2018 Early Career Award from IFMBE/IAMBE (only 3 awardees internationally, each with 5000$ & an invited talk at IFMBE/IAMBE/IUPESM).


  • SINGAPORE 1.1.18: A/Prof. Mehul Motani is named a Fellow of IEEE.